ABBOTT LABORATORIES (ABT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 20B 40B 60B Q2 '21: 40.2B Q3 '21: 42.3B Q4 '21: 43.1B Q1 '22: 44.5B Q2 '22: 45.5B Q3 '22: 45B Q4 '22: 43.7B Q1 '23: 41.5B Q2 '23: 40.2B Q3 '23: 40B Q4 '23: 40.1B Q1 '24: 40.3B Q2 '24: 40.7B Q3 '24: 41.2B Q4 '24: 42B Q1 '25: 42.3B Q2 '25: 43.1B Q3 '25: 43.8B Q4 '25: 44.3B Q1 '26: 45.1B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Gross Profit TTM

0 6B 12B 18B Q1 '15: 10.8B Q2 '15: 10.9B Q3 '15: 11.1B Q4 '15: 11.1B Q1 '16: 11B Q2 '16: 11.1B Q3 '16: 11.2B Q4 '16: 11.3B Q1 '17: 11.4B Q2 '17: 11.6B Q3 '17: 12.2B Q4 '17: 13B Q1 '18: 14B Q2 '18: 14.9B Q3 '18: 15.4B Q4 '18: 15.7B Q1 '19: 15.8B Q2 '19: 16.1B Q3 '19: 16.4B Q4 '19: 16.7B Q2 '15 Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19

Operating Income TTM

0 3.5B 7B 10.5B Q2 '21: 7.4B Q3 '21: 8.5B Q4 '21: 8.4B Q1 '22: 9.2B Q2 '22: 10.2B Q3 '22: 9.4B Q4 '22: 8.4B Q1 '23: 7B Q2 '23: 6.1B Q3 '23: 6B Q4 '23: 6.5B Q1 '24: 6.4B Q2 '24: 6.5B Q3 '24: 6.7B Q4 '24: 6.8B Q1 '25: 7.1B Q2 '25: 7.5B Q3 '25: 7.7B Q4 '25: 8.1B Q1 '26: 7.7B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Net Income TTM

0 5B 10B 15B Q2 '21: 6.4B Q3 '21: 7.2B Q4 '21: 7.1B Q1 '22: 7.7B Q2 '22: 8.6B Q3 '22: 7.9B Q4 '22: 6.9B Q1 '23: 5.8B Q2 '23: 5.2B Q3 '23: 5.2B Q4 '23: 5.7B Q1 '24: 5.6B Q2 '24: 5.6B Q3 '24: 5.8B Q4 '24: 13.4B Q1 '25: 13.5B Q2 '25: 14B Q3 '25: 14B Q4 '25: 6.5B Q1 '26: 6.3B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Cost of Revenue TTM

0 7B 14B 21B Q2 '21: 17.8B Q3 '21: 18.3B Q4 '21: 18.5B Q1 '22: 19.1B Q2 '22: 19.1B Q3 '22: 19.3B Q4 '22: 19.1B Q1 '23: 18.5B Q2 '23: 18B Q3 '23: 18B Q4 '23: 18B Q1 '24: 18.1B Q2 '24: 18.2B Q3 '24: 18.3B Q4 '24: 18.7B Q1 '25: 18.7B Q2 '25: 19B Q3 '25: 19.3B Q4 '25: 19.3B Q1 '26: 19.7B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Cash Flow TTM

0 4B 8B 12B Q2 '21: 10.6B Q3 '21: 11.3B Q4 '21: 10.5B Q1 '22: 10B Q2 '22: 10.2B Q3 '22: 10.3B Q4 '22: 9.6B Q1 '23: 8.7B Q2 '23: 7.5B Q3 '23: 6.5B Q4 '23: 7.3B Q1 '24: 7.1B Q2 '24: 7.9B Q3 '24: 8.7B Q4 '24: 8.6B Q1 '25: 8.9B Q2 '25: 9B Q3 '25: 9.1B Q4 '25: 9.6B Q1 '26: 9.5B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Free Cash Flow TTM

0 3.5B 7B 10.5B Q2 '21: 8.6B Q3 '21: 9.3B Q4 '21: 8.6B Q1 '22: 8.2B Q2 '22: 8.5B Q3 '22: 8.5B Q4 '22: 7.8B Q1 '23: 6.8B Q2 '23: 5.5B Q3 '23: 4.5B Q4 '23: 5.1B Q1 '24: 4.9B Q2 '24: 5.7B Q3 '24: 6.5B Q4 '24: 6.4B Q1 '25: 6.7B Q2 '25: 6.8B Q3 '25: 6.9B Q4 '25: 7.4B Q1 '26: 7.4B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 700M 1.4B 2.1B Q3 '19: 1.8B Q1 '20: 1.8B Q2 '20: 1.8B Q3 '20: 1.8B Q1 '21: 1.8B Q2 '21: 1.8B Q3 '21: 1.8B Q1 '22: 1.8B Q2 '22: 1.8B Q3 '22: 1.8B Q1 '23: 1.8B Q2 '23: 1.8B Q3 '23: 1.7B Q1 '24: 1.7B Q2 '24: 1.8B Q3 '24: 1.7B Q1 '25: 1.7B Q2 '25: 1.8B Q3 '25: 1.7B Q1 '26: 1.7B Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.00 6.00 9.00 Q2 '21: 3.55 Q3 '21: 4.03 Q4 '21: 3.94 Q1 '22: 4.31 Q2 '22: 4.79 Q3 '22: 4.43 Q4 '22: 3.91 Q1 '23: 3.29 Q2 '23: 2.93 Q3 '23: 2.94 Q4 '23: 3.26 Q1 '24: 3.21 Q2 '24: 3.17 Q3 '24: 3.29 Q4 '24: 7.64 Q1 '25: 7.70 Q2 '25: 7.97 Q3 '25: 7.97 Q4 '25: 3.73 Q1 '26: 3.58 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.